Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly

Additional Metadata
Persistent URL	doi.org/10.1210/jc.2014-2032, hdl.handle.net/1765/87278
Journal	Journal of Clinical Endocrinology and Metabolism
Organisation	Department of Internal Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Neggers, B., Franck, S., de Rooij, F., Dallenga, A. H. G., Poublon, R., Feelders, R., Janssen, J., Buchfelder, M., Hofland, L., Jørgensen, J. O.& van der Lely, A.-J. (2014). Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly. Journal of Clinical Endocrinology and Metabolism, 99(10), 3644–3652.https://doi.org/10.1210/jc.2014-2032

Publication